Clinical Trial

Longitudinal Observational Study on the Course of Cystic Fibrosis Lung Disease in Patients Following Newborn Screening

Study acronym: TRACK-CF
Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of this study is to further characterize early CF lung disease in newborns, infants and toddlers with cystic fibrosis (CF).
Protocol Amendment History 8 amendments
This ClinicalTrials.gov record has been amended 8 times since 2014-10-16; most recent amendment 2023-11-28.
Trial Details
NCT Number NCT02270476
Lead Sponsor Heidelberg University
Collaborators: German Center for Lung Research
Conditions Cystic Fibrosis Lung Disease
Enrollment 200 participants
Start Date 2011-12
Primary Completion 2030-12 (estimated)
Study Completion 2030-12 (estimated)
Updated on ClinicalTrials.gov 2023-11-29